Trials / Completed
CompletedNCT00892008
A Post Marketing Surveillance Study On Pregabalin (Lyrica) On Efficacy, Safety And Tolerability Of Pregabalin
Pregabalin (Lyrica) Action In Neuropathic Pain Syndrome (PAINS): A Post Marketing Surveillance Study On Efficacy, Safety And Tolerability Of Pregabalin
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,278 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is being conducted as a regulatory requirement post initial marketing authorization. This is primarily a safety study. This was an open label study and patients were enrolled once the decision to prescribe the medication was made by the Investigator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin | Pregabalin 75-150 mg BID for at least 2 weeks. |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2008-08-01
- Completion
- 2008-08-01
- First posted
- 2009-05-01
- Last updated
- 2021-01-25
- Results posted
- 2009-11-18
Source: ClinicalTrials.gov record NCT00892008. Inclusion in this directory is not an endorsement.